The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 07, 2019
Filed:
Aug. 25, 2017
Applicant:
Calithera Biosciences, Inc., South San Francisco, CA (US);
Inventors:
Francesco Parlati, San Francisco, CA (US);
Keith Orford, Doylestown, PA (US);
Sam H. Whiting, Seattle, WA (US);
Assignee:
Calithera Biosciences, Inc., South San Francisco, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/501 (2006.01); A61K 31/4439 (2006.01); A61K 31/4545 (2006.01); A61K 31/47 (2006.01); A61K 45/06 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
A61K 31/501 (2013.01); A61K 31/4439 (2013.01); A61K 31/4545 (2013.01); A61K 31/47 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01);
Abstract
The invention relates to methods of treating cancer or myeloproliferative diseases with a combination of a glutaminase inhibitor and an anticancer agent selected from cabozantinib, crizotinib, and axitinib. The invention further relates to methods of treating cancer or myeloproliferative diseases that are resistant to one or more anticancer agents.